Search Results
Feb 18, 2026, 08:31 ET Coaqua, a Leading Super Premium Coconut Water Crushing the Better for You Beverage Category, Appoints Ex-Liquid Death Social Media Expert, Kendyl Vanscoy, to Lead Social Media, Marketing, Experiential and Brand Development
Day Squares and Everyday Dose in addition to her work with Liquid Death."The way we connected with Kendyl initially - via a DM from her on social media - speaks to her true passion and authentic love for all things social media and branding related," states Anthony Cadieux II,
More news about: Coaqua
Feb 18, 2026, 06:45 ET Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
10.1001/jamadermatol.2024.1677 11 Weight-related comorbidities in study participants included cardiovascular disease, type 2 diabetes mellitus (T2DM), dyslipidemia, hypertension, obstructive sleep apnea (OSA). Participants had an average of 14.6 years since their psoriasis diagnosis. High-impact body
More news about: Eli Lilly and Company
Feb 13, 2026, 15:50 ET In HelloNation, Generator Expert Dan Shaver of Clayton, NY, Shares Generator Installation Tips for Cold Weather Climates
installing a generator, especially one for use in a cold weather climate,requires far more attention to detail than many homeowners realize. Dan Shaver of DM Shaver Inc. in Clayton, New York, explains how generator installation errors can reduce performance and reliability, especially in regions like Northern
More news about: HelloNation
Feb 13, 2026, 06:38 ET Resume.org Survey: 3 in 10 Singles Use LinkedIn as a Dating App and Invite Coworkers To Slide Into Their DMs
56% from clients, and 55% even from strangers.Outreach appears to be largely successful. Among single LinkedIn users who have sent a romantic DM, 66% say they received a positive reply and continued the conversation, while 21% received a response but the person was not interested. Fewer than 2%
More news about: Resume.org
Feb 05, 2026, 09:03 ET MasterClass Launches Rebuild Your Focus & Reclaim Your Time With Cal Newport to Help Members Escape Burnout and Work Smarter
https://dam.masterclass.com/Share/ih517b5g4740gwev5t565o5dm2k266egCredit: Courtesy of MasterClassAbout MasterClass:
More news about: MasterClass
Feb 05, 2026, 08:31 ET Gen Z's Secret Love Lives Exposed: 1 in 3 Caught Texting During Sex (And 24 Texted Mom Back)
exactly one person from your campus—no doubles, no overlaps, just one compatibility score and a week of anticipation. Seven days later, you'll get a DM revealing your match's name. Will it be your lab partner? That person from your philosophy class? Your roommate's ex? The algorithm knows, and you're
More news about: Yik Yak
Feb 04, 2026, 08:00 ET MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
fibrosis, and improved glucose control. Furthermore, in Phase 1a, 1b and 2a trials, vanoglipel was well tolerated in both healthy volunteers and those with T2DM. In a Phase 2a clinical study, vanoglipel demonstrated direct hepatic action in addition to its glucose lowering effects.About SyntekabioSyntekabio
More news about: MetaVia Inc.
Feb 03, 2026, 16:01 ET AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
tested.Daxdilimab showed an acceptable safety and tolerability profile.A Phase 2 study of daxdilimab in 12 patients with dermatomyositis (DM) and antisynthetase inflammatory myositis (ASIM) is complete.Total Improvement Score (TIS) and Cutaneous Dermatomyositis Disease
More news about: Amgen
Feb 02, 2026, 21:44 ET Avidity Biosciences Announces Expected Record Date for Spin-Off
targeted delivery of RNA into muscle and is leading the field with clinical development programs for three rare muscle diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Avidity is also advancing two wholly owned precision cardiology
More news about: Avidity Biosciences, Inc.
Feb 02, 2026, 09:00 ET New Bridgestone Blizzak IcePeak Tire with ENLITEN™ Technology Features Ice Grip Certification and New Design for Even Greater Winter Performance and Control
Launching nationally in May 2026, the Blizzak IcePeak tire replaces two tires in the Bridgestone lineup—the Blizzak WS90 tire and the Blizzak DM-V2 tire—providing exceptional winter performance for sedans, minivans, CUVs, SUVs and trucks. The new tire will be offered in 107 sizes from 14- to
More news about: Bridgestone Americas, Inc.
Feb 02, 2026, 09:00 ET Malwarebytes Makes ChatGPT Smarter About Scams, Malware and Online Risk
angle."What you can do with Malwarebytes in ChatGPTSpot scams faster: Share the contents of any text message, email or DM and get a clear, point-by-point assessment of phishing signals and social‑engineering red flags, plus safer next steps.Check suspicious links,
More news about: Malwarebytes
Jan 30, 2026, 09:00 ET Tous les Jours Partners with Rakuten Viki for Valentine's Day Promotion
States. All entries must be received by 11:59 p.m. PST on February 14, 2026, and winners will be selected at random and contacted directly via Instagram DM. Full terms and conditions can be found
More news about: Tous les Jours
Jan 27, 2026, 08:50 ET Mind Over Media and Skipify Eliminate Redirects from Agentic Commerce with True Conversational "Checkout-in-Chat"
conversion without compromise. For the first time, a brand's AI can guide a customer from discovery to a completed purchase inside a single Instagram DM, with zero redirects. That is the holy grail of digital commerce, and our partnership with Skipify makes it a reality."At the core of the integration
More news about: Skipify
Jan 13, 2026, 13:59 ET Firstsource Acquires TeleMedik To Bolster Digital Offerings and Expand Presence in U.S. Healthcare Payer and Provider Markets
enabling Firstsource to deliver more enhanced capabilities in Utilization Management (UM), Care Management (CM), Disease Management (DM), and Population Health.Driving significant improvements in core administration and UM efficiency with combined technology
More news about: Firstsource
Jan 13, 2026, 08:00 ET Frankenmuth Insurance Selects Duck Creek OnDemand Distribution Management to Transform Agency and Producer Management
New cloud-based DM enables Frankenmuth to enhance compliance, accelerate agent onboarding, and improve partner performance BOSTON, Jan. 13, 2026
More news about: Duck Creek Technologies, Inc.
Jan 12, 2026, 09:00 ET Mandara Biopharma Files IND with the FDA to Advance Dronabinol Oral Solution Formulation for Alzheimer's Agitation
[email protected] Lim MM, Gerstner JR, Holtzman DM. The sleep-wake cycle and Alzheimer's disease: What do we know? Neurodegenerative Disease Management 2014; 4(5): 351-3622 Cloutier,
More news about: Mandara Biopharma Inc.
Jan 08, 2026, 14:00 ET Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight
care-seeking adults in the US in 2024, Truveta (data on file). Comorbidities include atherosclerotic cardiovascular disease (ASCVD), type 2 diabetes mellitus (T2DM), dyslipidemia, hypertension, obstructive sleep apnea (OSA).
More news about: Eli Lilly and Company
Jan 08, 2026, 02:36 ET CES 2026 Highlight Debut: Daimon Robotics' DM-EXton2, the World's First Haptic Feedback Teleoperation Data Acquisition System
2026 /PRNewswire/ -- The 2026 Consumer Electronics Show (CES) recently took place in Las Vegas. During the exhibition, Daimon Robotics unveiled the DM-EXton2—the world's first haptic feedback teleoperation data acquisition system. It directly addresses the critical bottleneck of "high-quality training
More news about: Daimon Robotics
Jan 08, 2026, 02:13 ET CES 2026 Highlight Debut: Daimon Robotics' DM-EXton2, the World's First Haptic Feedback Teleoperation Data Acquisition System
2026 /PRNewswire/ -- The 2026 Consumer Electronics Show (CES) recently took place in Las Vegas. During the exhibition, Daimon Robotics unveiled the DM-EXton2—the world's first haptic feedback teleoperation data acquisition system. It directly addresses the critical bottleneck of "high-quality training
More news about: Daimon Robotics
Jan 07, 2026, 08:00 ET Vuzix and Himax to Introduce a Lightweight, Prescription-Ready Optical Component Reference Design for AR Glasses at CES 2026
and integration support provided jointly by Vuzix and Himax.OEMs, eyewear makers, and partners are invited to meet with the teams during CES. DM to schedule an appointment.About Vuzix Corporation Vuzix is a leading designer, manufacturer and marketer of AI-powered Smart Glasses,
More news about: Vuzix Corporation
Jan 06, 2026, 03:19 ET Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Orforglipron developed by Eli Lilly and Co | Obesity and T2DMA once-daily, oral small-molecule GLP-1 RA for managing overweight/obesity and T2DM, also under investigation for obstructive sleep apnea and hypertension in individuals with obesity.
More news about: Clarivate Plc
Jan 06, 2026, 03:07 ET Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Orforglipron developed by Eli Lilly and Co | Obesity and T2DMA once-daily, oral small-molecule GLP-1 RA for managing overweight/obesity and T2DM, also under investigation for obstructive sleep apnea and hypertension in individuals with obesity.
More news about: Clarivate Plc
Jan 01, 2026, 01:00 ET ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
currently in a Phase 2 clinical trial for Polymyositis (PM) and Dermatomyositis (DM) in South Korea. Recognizing its therapeutic potential, the U.S. FDA has granted Orphan Drug Designation (ODD) to PF1801 for PM, DM, and Duchenne Muscular Dystrophy (DMD). Additionally, PF1804 (pemziviptadil)
More news about: ImmunoForge
Dec 25, 2025, 07:05 ET transcosmos and V, Inc. launch metaverse creator services for VRChat via Geek Jack, transcosmos's cross-border e-commerce site for entertainment items
・DM (Direct Mail): Handles inquiries from
More news about: transcosmos inc.
Dec 23, 2025, 13:50 ET DoubleLine Report: Developed Markets' Sovereign Debt No Longer a Presumed Safe Haven
TAMPA, Fla., Dec. 23, 2025 /PRNewswire/ -- The sovereign debt of developed market (DM) countries, for decades largely perceived to float free of governance and societal risks endemic to the emerging markets (EM), no longer can be presumed
More news about: DoubleLine